Monamidocin, a Novel Fibrinogen Receptor Antagonist I.Production, Isolation, Characterization and Structural Elucidation
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-11-25
著者
-
Satoh Tomoko
Nippon Roche Research Center
-
ITEZONO Yoshiko
Nippon Roche Research Center
-
NAKAYAMA Noboru
Nippon Roche Research Center
-
WATANABE Junko
Saitama Cancer Center Research Institute
-
Anzai Yojiro
Nippon Roche Research Center
-
Watanabe J
Saitama Cancer Center Research Institute
-
KAMIYAMA Tsutomu
Nippon Roche Research Center
-
UMINO Takayuki
Nippon Roche Research Center
-
YOKOSE Kazuteru
Nippon Roche Research Center
-
TAKEMAE Asako
Nippon Roche Research Center
-
WATANABE Junko
Nippon Roche Research Center
-
Kamiyama T
Nippon Roche Res. Center Kanagawa Jpn
関連論文
- Cyclothialidine Analogs, Novel DNA Gyrase Inhibitors
- Structural Elucidation of Aculeximycin IV.Absolute Structure of Aculeximycin, Belonging to a New Class of Macrolide Antibiotics
- Structural Elucidation of Aculeximycin III.Planar Structure of Aculeximycin, Belonging to a New Class of Macrolide Antibiotics
- The Structures of Two Lindenane Sesquiterpene Glucosides from Chloranthus glaber
- Nucleocytoplasmic Shuttling of the Aryl Hydrocarbon Receptor^1
- Screening of an Inhibitor of the Tetracycline Efflux Pump is a Tetracycline-Resistant Clinical-Isolate of Staphylococcus aureus 743
- Monamidocin, a Novel Fibrinogen Receptor Antagonist II.Biological Activity and Structure-activity Relationships
- Monamidocin, a Novel Fibrinogen Receptor Antagonist I.Production, Isolation, Characterization and Structural Elucidation
- Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists II.Structural Elucidation
- Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists I.Production, Isolation, Characterization and Biological Activities
- Characterization of the LxxLL Motif in the Aryl Hydrocarbon Receptor : Effects on Subcellular Localization and Transcriptional Activity
- 16S rRNA Gene Sequence Analysis of Streptomyces lavendulae and Streptomyces virginiae Strains
- SYNTHESIS AND ANTITUMOR ACTIVITY OF 5'-DEOXY-5-FLUOROCYTIDINE (5'-DFCR) DERIVATIVES